6-(4-Benzyl-6-oxo-1,6-dihydro-pyrimidin-2-ylsulfanyl)-hexanoic acid hydroxyamide

ID: ALA218027

Chembl Id: CHEMBL218027

PubChem CID: 135513126

Max Phase: Preclinical

Molecular Formula: C17H21N3O3S

Molecular Weight: 347.44

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C(CCCCCSc1nc(Cc2ccccc2)cc(=O)[nH]1)NO

Standard InChI:  InChI=1S/C17H21N3O3S/c21-15(20-23)9-5-2-6-10-24-17-18-14(12-16(22)19-17)11-13-7-3-1-4-8-13/h1,3-4,7-8,12,23H,2,5-6,9-11H2,(H,20,21)(H,18,19,22)

Standard InChI Key:  YDVCEIGTXDMBFG-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA218027

    ---

Associated Targets(Human)

U-937 (7138 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

hda106 Histone deacetylase HD2 (351 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Hdac1 Histone deacetylase 1 (93 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
hd1b Histone deacetylase HD1B (86 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Candida albicans (78123 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 347.44Molecular Weight (Monoisotopic): 347.1304AlogP: 2.52#Rotatable Bonds: 9
Polar Surface Area: 95.08Molecular Species: NEUTRALHBA: 5HBD: 3
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: 7.69CX Basic pKa: 0.34CX LogP: 2.70CX LogD: 2.54
Aromatic Rings: 2Heavy Atoms: 24QED Weighted: 0.21Np Likeness Score: -1.03

References

1. Mai A, Massa S, Rotili D, Pezzi R, Bottoni P, Scatena R, Meraner J, Brosch G..  (2005)  Exploring the connection unit in the HDAC inhibitor pharmacophore model: novel uracil-based hydroxamates.,  15  (21): [PMID:16165353] [10.1016/j.bmcl.2005.07.081]
2. Mai A, Massa S, Rotili D, Simeoni S, Ragno R, Botta G, Nebbioso A, Miceli M, Altucci L, Brosch G..  (2006)  Synthesis and biological properties of novel, uracil-containing histone deacetylase inhibitors.,  49  (20): [PMID:17004718] [10.1021/jm0605536]
3. Mai A, Rotili D, Massa S, Brosch G, Simonetti G, Passariello C, Palamara AT..  (2007)  Discovery of uracil-based histone deacetylase inhibitors able to reduce acquired antifungal resistance and trailing growth in Candida albicans.,  17  (5): [PMID:17196388] [10.1016/j.bmcl.2006.12.028]
4. Paris M, Porcelloni M, Binaschi M, Fattori D..  (2008)  Histone deacetylase inhibitors: from bench to clinic.,  51  (6): [PMID:18247554] [10.1021/jm7011408]

Source